2 suspended. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder Tocilizumab, Placebo, Whole-Body Hyperthermia - Major Depressive Disorder | Phase 2 | Suspended | Massachusetts General Hospital | 35 | 2026-12-01 | 2025-11-13 |
| Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV Pramipexole ER, Escitalopram - Major Depressive Disorder, Mild Neurocognitive Disorder | Phase 2 | Suspended | National Institute of Allergy and Infectious Diseases (NIAID) | 186 | 2026-05-17 | 2026-07-14 |
Depressive Disorder, Major (2) · Depression (1) · Hyperthermia (1) · Inflammation (1) · Neurocognitive Disorders (1)
Depressive Disorder (2) · Mental Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Body Temperature Changes (1) · Heat Stress Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Wounds and Injuries (1)
Escitalopram (1) · Sodium Chloride (1) · tocilizumab (1)
Massachusetts General Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · Botswana (1) · Brazil (1) · India (1) · Kenya (1) · Malawi (1) · Mexico (1) · Peru (1) · Philippines (1) · South Africa (1) · Thailand (1) · Uganda (1) · Vietnam (1) · Zimbabwe (1)
Scott Letendre, MD (1) · William R Short, MD (1)